Literature DB >> 24382414

Time course label-free quantitative analysis of cardiac muscles of rats after myocardial infarction.

Chun Li1, Qi Qiu, Yong Wang, Ping Li, Cheng Xiao, Hongxia Wang, Yang Lin, Wei Wang.   

Abstract

Heart failure is a worldwide cause of mortality and morbidity and is the ultimate ending of a variety of complex diseases. This reflects our incomplete understanding of its underlying molecular mechanisms and furthermore increases the complexity of the disease. To better understand the molecular mechanisms of heart failure, we investigated dynamic proteomic differences between the heart tissue of myocardial infarction rats and the rats in the sham group at days 4, 14, 28, 45 after operation. Using a label-free quantitative proteomic approach based on nanoscale ultra-performance liquid chromatography-ESI-MS(E), 133 proteins were identified at the four time points in 8 groups. 13 non-redundant proteins changed dynamically after acute myocardial infarction (AMI) in rat left ventricular (LV) tissue, including cytoskeletal proteins, metabolic enzymes, oxidative stress related proteins and ion channel proteins. The network analysis showed that the differential protein might play an important role in lipid metabolism and hypertrophic cardiomyopathy. The dynamic changes in the expression of beta-actin, alpha B-crystallin (CryAB), heat shock protein 8(HSP8), desmin and l-lactate dehydrogenase B (LDHB) were tested by the western-blot assay, and the results were consistent with the label-free quantitative proteomic results. Correlative analysis indicates that the CryAB and desmin have a better linear relation with heart function (ejection fraction) than cardiac troponin T (cTNT). Our results provide the first experimental evidence of the proteins that are differentially expressed following myocardial infarction, using time-course label-free quantitative proteomics in vivo without ischemia-reperfusion injury or myocardial ischemia. These differential functional proteins (especially CryAB and desmin) have different patterns during the myocardial infarction, which may partially account for the underlying mechanisms involved in cardiac rehabilitation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24382414     DOI: 10.1039/c3mb70422j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  6 in total

Review 1.  Quantitative proteomics in cardiovascular research: global and targeted strategies.

Authors:  Xiaomeng Shen; Rebeccah Young; John M Canty; Jun Qu
Journal:  Proteomics Clin Appl       Date:  2014-07-14       Impact factor: 3.494

2.  Cardiac protein changes in rats after soybean oil treatment: a proteomic study.

Authors:  Taisla Soprani; Vinicius Kuffer Uliana; Rogerio Faustino Ribeiro; Sergio Lisboa; Gabriella Xavier Maretto; André Teixeira Silva da Ferreira; Jonas Perales; Ivanita Stefanon; Suely Gomes de Figueiredo
Journal:  Lipids Health Dis       Date:  2015-04-14       Impact factor: 3.876

3.  Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism.

Authors:  Chun Li; Jing Wang; Qiyan Wang; Yi Zhang; Na Zhang; Linghui Lu; Yan Wu; Qian Zhang; Wei Wang; Yong Wang; Pengfei Tu
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

4.  Time Course of the Effects of Buxin Yishen Decoction in Promoting Heart Function and Inhibiting the Progression of Renal Fibrosis in Myocardial Infarction Caused Type 2 Cardiorenal Syndrome Rats.

Authors:  Qi Qiu; Jinglin Cao; Yong Wang; Yunnan Zhang; Yun Wei; Xiaoyan Hao; Yu Mu; Yang Lin
Journal:  Front Pharmacol       Date:  2019-10-23       Impact factor: 5.810

5.  Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model.

Authors:  Jie Wang; Md Nazim Uddin; Qian Li; Alidan Aierken; Ming-Yuan Li; Rui Wang; Qian-Zhi Yan; Dilare Adi; Ming-Tao Gai; Yun Wu
Journal:  Oxid Med Cell Longev       Date:  2022-02-21       Impact factor: 6.543

6.  Dynamic adaptation of myocardial proteome during heart failure development.

Authors:  Julia Rüdebusch; Alexander Benkner; Axel Poesch; Marcus Dörr; Uwe Völker; Karina Grube; Elke Hammer; Stephan B Felix
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.